ALK-Abelló A/S (AKBLF)
OTCMKTS · Delayed Price · Currency is USD
28.95
0.00 (0.00%)
At close: Jul 29, 2025
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of $6.46 billion as of August 1, 2025. Its market cap has increased by 29.06% in one year.
Market Cap
6.46B
Enterprise Value
6.51B
Revenue
827.03M
Ranking
n/a
PE Ratio
47.60
Stock Price
$28.95
Market Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 1.10B to 6.46B, an increase of 488.60%. That is a compound annual growth rate of 9.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 6.46B | 31.95% |
| Dec 30, 2024 | 4.90B | 47.54% |
| Dec 29, 2023 | 3.32B | 8.87% |
| Dec 30, 2022 | 3.05B | -46.82% |
| Dec 30, 2021 | 5.73B | 27.24% |
| Dec 30, 2020 | 4.51B | 68.58% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| CytoDyn | 371.08M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |